Sleep apnoea in patients after treatment of head neck cancer

Steffen, Armin; Graefe, Hendrik; Gehrking, E.; König, Inke R.; Wollenberg, Barbara

doi:10.1080/00016480802613113

Cited by 9 publications

(17 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of participants in the control groups (including cancer and noncancer) evaluated in studies was 1607. Only 90 studies (35%) included a comparison group in the study design, with most comparison groups being subjects with cancer.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

et al. 2014

View full text Add to dashboard Cite

Although sleep is vital to all human functioning and poor sleep is a known problem in cancer, it is unclear whether the overall prevalence of the various types of sleep disorders in cancer is known. The purpose of this systematic literature review was to evaluate if the prevalence of sleep disorders could be ascertained from the current body of literature regarding sleep in cancer. This was a critical and systematic review of peer-reviewed, English-language, original articles published from 1980 through 15 October 2013, identified using electronic search engines, a set of key words, and prespecified inclusion and exclusion criteria. Information from 254 full-text, English-language articles was abstracted onto a paper checklist by one reviewer, with a second reviewer randomly verifying 50% (k = 99%). All abstracted data were entered into an electronic database, verified for accuracy, and analyzed using descriptive statistics and frequencies in SPSS (v.20) (North Castle, NY). Studies of sleep and cancer focus on specific types of symptoms of poor sleep, and there are no published prevalence studies that focus on underlying sleep disorders. Challenging the current paradigm of the way sleep is studied in cancer could produce better clinical screening tools for use in oncology clinics leading to better triaging of patients with sleep complaints to sleep specialists, and overall improvement in sleep quality.

show abstract

Section: Resultsmentioning

confidence: 99%

“…When selecting participants for studies, potentially important inclusion and exclusion criteria for sleep were rarely addressed. For example, only 19.7% ( n = 50) of the studies reviewed excluded for previous sleep disorder or current treatment of sleep disorders.…”

Section: Resultsmentioning

confidence: 99%

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Literature data on OSAS and neck cancers are few, and the results are quite variable . In 2001, Friedman et al highlighted the link between OSAS and neck cancers.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of obstructive sleep apnoea syndrome following oropharyngeal cancer treatment: A prospective cohort study

Löth

Michel

Giorgi

et al. 2017

Clinical Otolaryngology

View full text Add to dashboard Cite

show abstract

“…The coincidence of sleep disorders and cancer has been described, and studies have even specifically looked at OSA in posttreatment HNSCC patients, which have yielded a wide range of OSA rates (8–92%) . Our objective was to isolate the effects of radiation therapy to the larynx and oropharynx on OSA by excluding patients who had undergone surgery.…”

Section: Discussionmentioning

confidence: 99%

“…HNSCC patients may experience upper airway obstruction and poor sleep quality from the mass effect of a pretreated or recurrent tumor itself, or from the anatomic and functional alterations related to RT, surgical ablation, and reconstruction . This significant anatomic and functional heterogeneity in HNSCC patients partially explains the wide range in previously reported prevalence rates of OSA in this population (8%–92%) …”

Section: Introductionmentioning

confidence: 99%